Broker Notes: Why analysts name Brambles and Doctor Care Anywhere to buy now?

$Zip (Z1P.AU)$: Jefferies cuts its target price by 46% to A$1.00 and maintains an underperform rating on the stock.

The fall in the value of transactions on buy-now-pay-later provider Zip's platform has Jefferies worried and is among several factors prompting the investment bank to slash its target price on the stock.

Shares are last traded at A$1.205.

$Brambles Ltd (BXB.AU)$: UBS maintains a buy rating and A$13.00 target price on the stock.

UBS says that free cash-flow will improve substantially when economic conditions stabilize and the price of lumber falls from current levels.

Shares are 0.83% lower at A$10.73.

$Doctor Care Anywhere Group PLC (DOC.AU)$: Bell Potter retains its buy call.

Doctor Care Anywhere's recent 1Q update showed another quarter of strong revenue growth, surprising on margins, Bell Potter says.

Shares are 1.85% higher at A$0.275.

$Challenger Ltd (CGF.AU)$: UBS raises the stock's target price 14% to A$7.30 and keeps its neutral rating.

Challenger's tightening of its FY 2022 guidance for net profit before tax should de-risk earnings into the August result, UBS says.

Shares are 5.20% lower at A$7.11.